Advertisement

5 Results

for author "Kausar J. Jabbar"

Type a term to search within all articles in this journal: e.g., stem cell
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
Date of Publication
e.g., 2017-01-17
e.g., 2017-01-17
Format Results
  • Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma
    Zijun Y. Xu-Monette, Ling Li, John C. Byrd, Kausar J. Jabbar, Ganiraju C. Manyam, Charlotte Maria de Winde, Michiel van den Brand, Alexandar Tzankov, Carlo Visco, Jing Wang, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Ben M. Parsons, Jane N. Winter, Michael Wang, Frederick B. Hagemeister, Miguel A. Piris, J. Han van Krieken, L. Jeffrey Medeiros, Yong Li, Annemiek B. van Spriel, Ken H. Young
    ...Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma Zijun Y. Xu-Monette 1 , * , Ling Li 2 , * , John C. Byrd 3 , Kausar J. Jabbar 1 , Ganiraju C. Manyam 4 ~~~
  • Updated Phase II Study of Targeted Subcutaneous (SC) Bortezomib for Patients with Low- or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) with Evidence of NF-κb Activation
    May Daher, Juliana Elisa Hidalgo Lopez, Jasleen K. Randhawa, Kausar Jabeen Jabbar, Naveen Pemmaraju, Gautam Borthakur, Tapan M. Kadia, Marina Konopleva, Hagop M. Kantarjian, Jorge E. Cortes, Katherine P. Hearn, Steven R. Reyes, Carlos E. Bueso-Ramos, Guillermo Garcia-Manero
    ...Reyes Hidalgo Juliana Elisa Hidalgo Lopez KJ Jabbar Guillermo, Garcia-Manero Jorge E, Cortes KatherineP Hearn Marina Steven Reyes Kantarjian, HM Randhawa, Jasleen K Hearn, Katherine P Kadia, T Kausar Jabeen Jabbar M Daher Cortes Jabbar Kausar Jabeen Elisa Lopez Hearn, K.P Kausar Jabeen, Jabbar Randhawa ~~~
  • Phase II Study of Targeted Subcutaneous (SC) Bortezomib for Patients with Low- or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) with Evidence of NF-κB Activation
    Jasleen K. Randhawa, Kausar Jabeen Jabbar, Tapan Kadia, Gautam Borthakur, Naveen Pemmaraju, Naval Daver, Hagop M. Kantarjian, Jorge E. Cortes, Katherine Hearn, Carlos E. Bueso-Ramos, Guillermo Garcia-Manero
    ...Cortes Jorge E. Hearn, Katherine Borthakur, G T Kadia Garcia-Manero, Guillermo Kantarjian JE Cortes Jasleen Kantarjian, H Jasleen K Garcia-Manero Guillermo H Kantarjian Bueso-Ramos, CE K.J. Jabbar Daver, N C.E. Bueso-Ramos JK Randhawa KJ Jabbar Guillermo, Garcia-Manero Jorge E, Cortes Kantarjian, HM ~~~
  • Pathobiology of Hemophilic Synovitis II: Synovial Cell Proliferation.
    Leonard A. Valentino, Narine Hakobyan, Tamara Kazarian, Adnan A. Jabbar, Kausar J. Jabbar
    ...KausarJ Jabbar KJ Jabbar Tamara Tamara Kazarian Tamara, Kazarian L Valentino Adnan A Jabbar Hakobyan, N Adnan Jabbar Kausar J, Jabbar Leonard A Kazarian Hakobyan, Narine N Hakobyan Valentino, LA Kazarian, Tamara Leonard A, Valentino Jabbar, K.J Kausar J Jabbar Pathobiology of Hemophilic Synovitis II ~~~
  • Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene
    Narine Hakobyan, Tamara Kazarian, Adnan A. Jabbar, Kausar J. Jabbar, Leonard A. Valentino
    ...Leonard A Valentino A Jabbar LA Valentino Jabbar, Adnan A Hakobyan Narine Valentino, L.A K.J. Jabbar A.A. Jabbar KausarJ Jabbar KJ Jabbar Tamara Tamara Kazarian Tamara, Kazarian L Valentino Adnan A Jabbar Hakobyan, N Adnan Jabbar Kausar J, Jabbar Leonard A Kazarian Valentino, LA Kazarian, Tamara N ~~~